Treatment of benign chronic gastric ulcer with ranitidine. A randomized, double-blind, and placebo-controlled six week trial. 1986

B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon

A randomized, multicenter, double-blind, placebo-controlled study was conducted to determine whether ranitidine 150 mg b.i.d. for 6 weeks would expedite endoscopic healing or relief of symptoms in patients with benign gastric ulcer. Of 203 patients enrolled, 101 received ranitidine and 102 received placebo. Endoscopic evaluations were conducted at baseline and at 2 and 6 weeks. At 6 weeks 68% of the patients treated with ranitidine had healed compared with 53% in the placebo group (p = 0.02). In those patients who had not healed by 6 weeks, ranitidine provided greater relief from pain than placebo. More patients in the placebo group dropped out of the study because of worsening symptoms (13 versus 4, p = 0.04). No differences in laboratory abnormalities or incidence of adverse events were detected between the two study groups. These results indicate that ranitidine 150 mg b.i.d. is superior to placebo in the treatment of benign gastric ulcer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
December 1985, Singapore medical journal,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
June 1983, The New England journal of medicine,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
March 1990, The Journal of the Association of Physicians of India,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
January 1984, Annals of clinical research,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
January 1983, Digestion,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
June 1988, The Medical journal of Malaysia,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
February 1989, Journal of clinical gastroenterology,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
May 2003, The American journal of gastroenterology,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
April 1988, Chinese medical journal,
B I Hirschowitz, and V DeLuca, and D Graham, and S Lorber, and P Bright-Asare, and R Katon
January 1980, Acta gastroenterologica Latinoamericana,
Copied contents to your clipboard!